Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium
Kristine M. Abo, … , Darrell N. Kotton, Andrew A. Wilson
Kristine M. Abo, … , Darrell N. Kotton, Andrew A. Wilson
Published March 22, 2022
Citation Information: JCI Insight. 2022;7(6):e155589. https://doi.org/10.1172/jci.insight.155589.
View: Text | PDF
Resource and Technical Advance Stem cells

Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium

  • Text
  • PDF
Abstract

Type 2 alveolar epithelial cells (AT2s), facultative progenitor cells of the lung alveolus, play a vital role in the biology of the distal lung. In vitro model systems that incorporate human cells, recapitulate the biology of primary AT2s, and interface with the outside environment could serve as useful tools to elucidate functional characteristics of AT2s in homeostasis and disease. We and others recently adapted human induced pluripotent stem cell–derived AT2s (iAT2s) for air-liquid interface (ALI) culture. Here, we comprehensively characterize the effects of ALI culture on iAT2s and benchmark their transcriptional profile relative to both freshly sorted and cultured primary human fetal and adult AT2s. We find that iAT2s cultured at ALI maintain an AT2 phenotype while upregulating expression of transcripts associated with AT2 maturation. We then leverage this platform to assay the effects of exposure to clinically significant, inhaled toxicants including cigarette smoke and electronic cigarette vapor.

Authors

Kristine M. Abo, Julio Sainz de Aja, Jonathan Lindstrom-Vautrin, Konstantinos-Dionysios Alysandratos, Alexsia Richards, Carolina Garcia-de-Alba, Jessie Huang, Olivia T. Hix, Rhiannon B. Werder, Esther Bullitt, Anne Hinds, Isaac Falconer, Carlos Villacorta-Martin, Rudolf Jaenisch, Carla F. Kim, Darrell N. Kotton, Andrew A. Wilson

×

Figure 2

iAT2 maturation in ALI culture is associated with decreased cell cycling.

Options: View larger image (or click on image) Download as PowerPoint
iAT2 maturation in ALI culture is associated with decreased cell cycling...
(A) SPRING plot of iAT2s cultured in 3D, ALI, or 2D profiled by scRNA-Seq on day 10 after passage, colored by cell culture format. (B) Heatmap of top 10 differentially expressed genes per sample. (C) Violin plots of module scores for AT2 maturation genes, lamellar body–associated genes, and genes that are decreased with AT2 maturation (1-way ANOVA). (D) qPCR of SFTPA1, SFTPA2, SLPI, and SOX9 at 1, 3, 7, and 10 days after passage in iAT2s cultured at 3D or ALI (unpaired 2-tailed Student’s t test, n = 3). (E) SPRING plot of iAT2s cultured in 3D, ALI, and 2D profiled on day 10 after passage by scRNA-Seq, colored by inferred cell cycle phase; quantification of inferred cell cycle phase by cell culture format. (F) Flow cytometry plots of iAT2s exposed to a 24-hour pulse of EdU and collected on day 10 after passage (unpaired 2-tailed Student’s t test, n = 3). (G) Violin plots of AT2 maturation gene module score by cell cycle phase and cell culture format. Data are shown as mean ± SD. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts